Holen Sie sich die Stockscreener-App
3.30
3.79%
-0.13
Handel nachbörslich:
3.31
0.01
+0.30%
Schlusskurs vom Vortag:
$3.43
Offen:
$3.44
24-Stunden-Volumen:
779.19K
Relative Volume:
1.20
Marktkapitalisierung:
$150.58M
Einnahmen:
$103.00K
Nettoeinkommen (Verlust:
$-42.47M
KGV:
-0.6077
EPS:
-5.43
Netto-Cashflow:
$-34.30M
1W Leistung:
+3.45%
1M Leistung:
+9.63%
6M Leistung:
+75.53%
1J Leistung:
+71.88%
1-Tages-Spanne:
$3.25
$3.47
1-Wochen-Bereich:
$3.14
$3.95
52-Wochen-Spanne:
$1.36
$3.97
Checkpoint Therapeutics Inc Stock (CKPT) Company Profile
Firmenname
Checkpoint Therapeutics Inc
Sektor
Branche
Telefon
781-652-4500
Adresse
95 SAWYER ROAD, WALTHAM, NY
Vergleichen Sie CKPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CKPT | 3.30 | 150.58M | 103.00K | -42.47M | -34.30M | -5.43 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Checkpoint Therapeutics Inc Stock (CKPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-06-09 | Eingeleitet | B. Riley Securities | Buy |
| 2021-01-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-05-29 | Eingeleitet | Lake Street | Buy |
| 2017-12-08 | Eingeleitet | H.C. Wainwright | Buy |
Checkpoint Therapeutics Inc Aktie (CKPT) Neueste Nachrichten
Checkpoint Therapeutics’ (CKPT) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
FY2024 Earnings Forecast for CKPT Issued By HC Wainwright - MarketBeat
Checkpoint Therapeutics Third Quarter 2024 Earnings: US$0.23 loss per share (vs US$0.29 loss in 3Q 2023) - Yahoo Finance
ARMISTICE CAPITAL, LLC Acquires Significant Stake in Checkpoint Therapeutics Inc - GuruFocus.com
Checkpoint Therapeutics: Preparing For Cosibelimab’s Upcoming PDUFA Date (NASDAQ:CKPT) - Seeking Alpha
Caterpillar Inc (CAT-N) QuotePress Release - The Globe and Mail
Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail
Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewswire
TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail
Checkpoint Therapeutics Sets FDA Review Date, Secures $9.2M Funding Boost Amid Q3 Loss | FBIO Stock News - StockTitan
S&P Midcap Micro (OMZ23) Quote - The Globe and Mail
S&P 500 ESG (ESG) QuotePress Release - The Globe and Mail
Vimeo Inc (VMEO-Q) QuotePress Release - The Globe and Mail
What Analysts Were Expecting After Checkpoint Therapeutics Inc (NASDAQ: CKPT) rose 2.03% - Stocks Register
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims o - GuruFocus.com
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Short Interest Update - MarketBeat
Kadant Inc (KAI-N) QuotePress Release - The Globe and Mail
Checkpoint Therapeutics stock hits 52-week high at $3.62 By Investing.com - Investing.com Australia
Checkpoint Therapeutics stock hits 52-week high at $3.62 - Investing.com
Toyota Motor Corp Ltd Ord ADR (TM-N) QuotePress Release - The Globe and Mail
Checkpoint Therapeutics Inc (CKPT) Is A Good Stock To Invest In - Stocks Register
Lucid Group Inc (LCID-Q) QuotePress Release - The Globe and Mail
Boston-area biotechs await drug approval decisions in coming months - The Business Journals
Do investors need to be concerned about Checkpoint Therapeutics Inc (CKPT)? - US Post News
Checkpoint Therapeutics Inc [CKPT] CEO, President and Director makes an insider sale of 24,610 shares worth $50450.0. – Knox Daily - Knox Daily
Checkpoint Therapeutics Inc (CKPT)’s results reveal risk - US Post News
Janux Therapeutics Inc [JANX] Stock sold by Insider Avalon Ventures XI, L.P. for $5.18 million - Knox Daily
Understanding the Risks of Investing in Harrow Inc (HROW) - Knox Daily
Checkpoint Therapeutics Inc [CKPT] stock was sold by Oliviero James F III at the price of US$50450.0 - Knox Daily
Recent Insider Activity Suggests Potential Gains for Corcept Therapeutics Inc (CORT) - Knox Daily
Acadia Pharmaceuticals Inc (ACAD) Becoming More Attractive for Investors - Knox Daily
Gain Therapeutics Inc [GANX] Investment Guide: What You Need to Know - Knox Daily
Viridian Therapeutics Inc (VRDN) receives a Buy rating from Needham - Knox Daily
Liberty Energy Inc [LBRT] Investment Appeal on the Rise - Knox Daily
Surf Air Mobility Inc [SRFM] Investment Guide: What You Need to Know - Knox Daily
Recent Insider Activity Could Benefit Opendoor Technologies Inc (OPEN) - Knox Daily
Howmet Aerospace Inc [HWM] Insider Activity: An Update for Investors - Knox Daily
Zentalis Pharmaceuticals Inc [ZNTL] Insider Vultaggio Vincent sells 1,603 Shares – Company Insider Activity - Knox Daily
Checking in on TG Therapeutics Inc (TGTX) after recent insiders movement - Knox Daily
Investing in SS&C Technologies Holdings Inc (SSNC): What You Must Know - Knox Daily
KBR Inc [KBR] stock was sold by Ibrahim Jalal at the price of US$2.33 million - Knox Daily
Confluent Inc (CFLT) receives a Neutral rating from Robert W. Baird - Knox Daily
Alnylam Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
The Attractiveness of Investing In Cerence Inc (CRNC) is Growing - Knox Daily
PHAT (Phathom Pharmaceuticals Inc) may reap gains as insiders became active recently - Knox Daily
KPTI’s latest rating updates from top analysts. - Knox Daily
Enphase Energy Inc (ENPH) receives a Mkt perform rating from William Blair - Knox Daily
Consol Energy Inc (CEIX) Becoming More Attractive for Investors - Knox Daily
Investing in Myriad Genetics, Inc. (MYGN): What You Must Know - Knox Daily
Rocket Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
Citigroup’s latest rating for CPRX stock - Knox Daily
Finanzdaten der Checkpoint Therapeutics Inc-Aktie (CKPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):